Why TherapeuticsMD (TXMD) Stock Is Surging Today

NEW YORK (TheStreet) -- TherapeuticsMD  (TXMD) surged Tuesday after FBR Capital initiated coverage on the pharmaceutical company with an "outperform" rating and a $34 price target.

FBR believes the company is well positioned to change the way in which doctors treat women with hormone replacement therapy. TherapeuticsMD's is developing its TX-001 HR for treating post-menopausal vasomotor symptoms such as hot flashes.

The stock was up 15.01% to $4.75 at 10:36 a.m. More than 5.8 million shares had changed hands, compared to the average volume of 1,167,370.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TXMD Price Chart

TXMD Price data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists